title: Intrathecal sodium nitroprusside improves cerebral blood flow and oxygenation in refractory cerebral vasospasm and ischemia in humans.
authors.forename: P
authors.initials: P
authors.lastname: Vajkoczy
authors.forename: U
authors.initials: U
authors.lastname: Hubner
authors.forename: P
authors.initials: P
authors.lastname: Horn
authors.forename: C
authors.initials: C
authors.lastname: Bauhuf
authors.forename: C
authors.initials: C
authors.lastname: Thome
authors.forename: L
authors.initials: L
authors.lastname: Schilling
authors.forename: P
authors.initials: P
authors.lastname: Schmiedek
authors.forename: M
authors.initials: M
authors.lastname: Quintel
authors.forename: J E
authors.initials: JE
authors.lastname: Thomas
mesh_terms: D002545:Brain Ischemia / Q000188:drug therapy* / Q000503:physiopathology; D002560:Cerebrovascular Circulation / Q000187:drug effects; D006801:Humans; D007278:Injections, Spinal; D009599:Nitroprusside / Q000008:administration & dosage*; D010101:Oxygen Consumption / Q000187:drug effects; D014665:Vasodilator Agents / Q000008:administration & dosage*; D020301:Vasospasm, Intracranial / Q000188:drug therapy* / Q000503:physiopathology
chemical_list: D014665:Vasodilator Agents; D009599:Nitroprusside